International Journal of Drug Delivery Technology
Volume 15, Issue 1

Formulation and Characterizationof Nanostructured Lipid Carrier (NLC) Based Gel for Topical Delivery of Resveratrol

Viraj Kamat1, Madan Pomaje1*, Ashwini Patil1, Akash Khetal2, Shruti Tikam1 

1Govindrao Nikam College of Pharmacy, Sawarde, Ratnagiri, Maharashtra 415606, India

2Shri Balasaheb Mane Shikshan Prasarak Mandals Ashokrao Mane College of Pharmacy, Peth Vadgaon, Kolhapur, Maharashtra, India 416112

Received: 20th Dec, 2024; Revised: 23rd Jan, 2025; Accepted: 27th Feb, 2025; Available Online: 25th Mar, 2025

ABSTRACT

Nanostructured lipid carriers based topical gel of Resveratrol was created with the aim of reducing inflammation. NLC is made up of propylene glycol as the co-surfactant, tween 20 as a surfactant, oleic acid as a liquid lipid, & stearic acid as a solid lipid. Particle size, SEM, DSC & FTIR were primarily utilised for analysing NLCs produced via solvent emulsification process. High entrapment efficiency, comprising 56.47% to 85.10%, has been demonstrated by the whole NLC. With 62.80nm of typical particle size & a 0.323 polydispersity index, which indicates uniformity in the distribution of particle sizes, formulation F1 was determined as the best formulation. Formulation F1's stability is shown by its larger zeta potential magnitude. The nanoparticulate dispersion was appropriately gelled & evaluated for in-vitro permeation study, homogeneity, spreadability, and physical appearance. The developed NLCs dispersion gel's in-vitro drug release pattern demonstrated both burst & prolong release. It was determined that resveratrol's created NLC gel shows promise for the drug's extended availability in skin tissues and may be applied to improve the treatment of inflammatory diseases.

Keywords: Resveratrol, Nanostructured Lipid Carrier (NLC), Topical Gel, Nanoparticle

How to cite this article: Viraj Kamat, Madan Pomaje, Ashwini Patil, Akash Khetal, Shruti Tikam. Formulation and Carectarization of Nanostructured Lipid Carrier (NLC) Based Gel for Topical Delivery of Resveratrol. International Journal of Drug Delivery Technology. 2025;15(1):159-67. doi: 10.25258/ijddt.15.1.22

REFERENCES

  1. Gad, S.; fawzy, mohammed; adel,  mohamed; Hamadi, T.; Ghourab, M. Nanostructured Lipid Carriers as Novel Drug Delivery System: A Review. Pharm. Biomed. Sci. 2023, 7 (3), 122–133. https://doi.org/10.21608/rpbs.2023.214962.1232.
  2. Nagaich, U.; Gulati, N. Nanostructured Lipid Carriers (NLC) Based Controlled Release Topical Gel of Clobetasol Propionate: Design and in Vivo Characterization. Drug Deliv. Transl. Res. 2016, 6 (3), 289–298. https://doi.org/10.1007/s13346-016-0291-1.
  3. Gu, Y.; Tang, X.; Yang, M.; Yang, D.; Liu, J. Transdermal Drug Delivery of Triptolide-Loaded Nanostructured Lipid Carriers: Preparation, Pharmacokinetic, and Evaluation for Rheumatoid Arthritis. J. Pharm. 2019, 554, 235–244. https://doi.org/10.1016/j.ijpharm.2018.11.024.
  4. Phatak, A. A.; Chaudhari, P. D. Development and Evaluation of Nanostructured Lipid Carrier (NLC) Based Topical Delivery of an Anti-Inflammatory Drug. Pharm. Res. 2013, 7 (8), 677–685. https://doi.org/10.1016/j.jopr.2013.08.020.
  5. Joshi, M.; Patravale, V. Nanostructured Lipid Carrier (NLC) Based Gel of Celecoxib. J. Pharm. 2008, 346 (1–2), 124–132. https://doi.org/10.1016/j.ijpharm.2007.05.060.
  6. Garg, N. K.; Sharma, G.; Singh, B.; Nirbhavane, P.; Tyagi, R. K.; Shukla, R.; Katare, O. P. Quality by Design (QbD)-Enabled Development of Aceclofenac Loaded-Nano Structured Lipid Carriers (NLCs): An Improved Dermatokinetic Profile for Inflammatory Disorder(S). J. Pharm. 2017, 517 (1–2), 413–431. https://doi.org/10.1016/j.ijpharm.2016.12.010.
  7. Azhar, S. N. A. S.; Ashari, S. E.; Zainuddin, N.; Hassan, M. Nanostructured Lipid Carriers-Hydrogels System for Drug Delivery: Nanohybrid Technology Perspective. Molecules 2022, 27 (1). https://doi.org/10.3390/molecules27010289.
  8. Astley, C.; Houacine, C.; Zaabalawi, A.; Wilkinson, F.; Lightfoot, A. P.; Alexander, Y.; Whitehead, D.; Singh, K. K.; Azzawi, M. Nanostructured Lipid Carriers Deliver Resveratrol, Restoring Attenuated Dilation in Small Coronary Arteries, via the AMPK Pathway. Biomedicines 2021, 9 (12). https://doi.org/10.3390/biomedicines9121852.
  9. Shirsath, N. R.; Goswami, A. K. Nanocarriers Based Novel Drug Delivery as Effective Drug Delivery: A Review. Nanomater. 2019, 4 (2), 71–83. https://doi.org/10.2174/2405461504666190527101436.
  10. Gao, S.; Tian, B.; Han, J.; Zhang, J.; Shi, Y.; Lv, Q.; Li, K. Enhanced Transdermal Delivery of Lornoxicam by Nanostructured Lipid Carrier Gels Modified with Polyarginine Peptide for Treatment of Carrageenan-Induced Rat Paw Edema. J. Nanomedicine 2019, 14, 6135–6150. https://doi.org/10.2147/IJN.S205295.
  11. Patel, D.; Dasgupta, S.; Dey, S.; Roja Ramani, Y.; Ray, S.; Mazumder, B. Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and in Vivo Evaluation. Pharm. 2012, 80 (3), 749–764. https://doi.org/10.3797/scipharm.1202-12.
  12. Ilyas, U.; Asif, M.; Wang, M.; Altaf, R.; Zafar, H.; Faran Ashraf Baig, M. M.; Paiva-Santos, A. C.; Abbas, M. Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes. Pharmacol. 2022, 13. https://doi.org/10.3389/fphar.2022.934156.
  13. Joshi, M.; Patravale, V. Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)-Based Gel of Valdecoxib. Drug Dev. Ind. Pharm. 2006, 32 (8), 911–918. https://doi.org/10.1080/03639040600814676.
  14. Rincón, M.; Calpena, A. C.; Fabrega, M. J.; Garduño-Ramírez, M. L.; Espina, M.; Rodríguez-Lagunas, M. J.; García, M. L.; Abrego, G. Development of Pranoprofen Loaded Nanostructured Lipid Carriers to Improve Its Release and Therapeutic Efficacy in Skin Inflammatory Disorders. Nanomaterials 2018, 8 (12). https://doi.org/10.3390/nano8121022.
  15. Agrawal, Y. O.; Mahajan, U. B.; Mahajan, H. S.; Ojha, S. Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, in-Vitro and in-Vivo Studies. J. Nanomedicine 2020, 15, 4763–4778. https://doi.org/10.2147/IJN.S247007.
  16. Govindarajan, R.; Rastogi, S.; Vijayakumar, M.; Shirwaikar, A.; Rawat, A. K. S.; Mehrotra, S.; Pushpangadan, P. Studies on the Antioxidant Activities of Desmodium Gangeticum. Pharm. Bull. 2003, 26 (10), 1424–1427. https://doi.org/10.1248/bpb.26.1424.
  17. Palei, N. N.; Mohanta, B. C.; Das, M. K.; Sabapathi, M. L. Lornoxicam Loaded Nanostructured Lipid Carriers for Topical Delivery: Optimization, Skin Uptake and in Vivo Studies. Drug Deliv. Sci. Technol. 2017, 39, 490–500. https://doi.org/10.1016/j.jddst.2017.05.001.